share_log

CASI Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-WEI-WU HE, Ph.D.(18.95%),EMERGING TECHNOLOGY PARTNERS, LLC(8.89%), etc.

CASI製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-WEI-WU HE, Ph.D.(18.95%),EMERGING TECHNOLOGY PARTNERS, LLC(8.89%)等

美股SEC公告 ·  2022/06/21 16:26
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息